Controversial statistical issues in clinical trials [electronic resource] / Shein-Chung Chow
- 作者： Chow, Shein-Chung 1955-
- 其他題名：
- Chapman & Hall/CRC biostatistics series
- 出版： Boca Raton : CRC Press c2011
- 叢書名： Chapman & Hall/CRC biostatistics series
- 主題： Drugs--Testing. , Drug development. , Clinical trials. , Clinical Trials as Topic , Drug Evaluation, Preclinical , Data Interpretation, Statistical.
- ISBN： 9781439849620 (electronic bk.)
- URL：
電子書
- 一般註：Description based on print version record
- 書目註：Includes bibliographical references (p. 553-575) and index
-
讀者標籤：
- 系統號： 005233798 | 機讀編目格式
館藏資訊
摘要註
"Preface In pharmaceutical/clinical development of a test drug or treatment, relevant clinical data are usually collected from subjects with the diseases under study in order to evaluate safety and efficacy of the test drug or treatment under investigation. To provide accurate and reliable assessment, well-controlled clinical trials under valid study design are necessarily conducted. Clinical trial process is a lengthy and costly process, which is necessary to ensure a fair and reliable assessment of the test treatment under investigation. Clinical trial process consists of protocol development, trial conduct, data collection, statistical analysis/interpretation, and reporting. In practice, controversial issues evitably occur regardless the compliance of good statistical practice (GSP) and good clinical practice (GCP). Controversial issues in clinical trials are referred to as debatable issues that are commonly encountered during the conduct of clinical trials. In practice, controversial issues could be raised from, but are not limited to, (1) compromises between theoretical and real/common practices, (2) miscommunication and/or misunderstanding in perception/interpretation among regulatory agencies, clinical scientists, and biostatisticians, and (3) disagreement, inconsistency, miscommunication/misunderstanding, and errors in clinical practice. "--Provided by publisher